Stockscreener 앱 받기
401.43
1.29%
-5.24
전일 마감가:
$406.67
열려 있는:
$410.35
하루 거래량:
8.11M
Relative Volume:
1.07
시가총액:
$360.32B
수익:
$450.13B
순이익/손실:
$14.91B
주가수익비율:
25.81
EPS:
15.551
순현금흐름:
$23.62B
1주 성능:
+5.83%
1개월 성능:
+6.97%
6개월 성능:
+26.87%
1년 성능:
+12.55%
1일 변동 폭
$395.52
$412.37
1주일 범위
$372.80
$414.12
52주 변동 폭
$255.97
$461.62
유나이티드헬스 그룹 Stock (UNH) Company Profile
명칭
Unitedhealth Group Inc
전화
1-800-328-5979
주소
1 HEALTH DRIVE, EDEN PRAIRIE
Compare UNH vs CVS, ELV, CI, HUM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UNH
Unitedhealth Group Inc
|
401.43 | 360.32B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
92.36 | 118.13B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
428.26 | 92.88B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
302.30 | 79.88B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
413.16 | 49.61B | 137.20B | 1.15B | 1.27B | 9.3439 |
유나이티드헬스 그룹 Stock (UNH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-08-27 | 다운그레이드 | Erste Group | Buy → Hold |
| 2026-07-16 | 업그레이드 | Robert W. Baird | Underperform → Neutral |
| 2026-06-17 | 재확인 | Leerink Partners | Outperform |
| 2026-06-04 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2026-04-27 | 업그레이드 | Erste Group | Hold → Buy |
| 2026-04-22 | 업그레이드 | Argus | Hold → Buy |
| 2026-04-07 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2026-04-01 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-10-14 | 개시 | Goldman | Buy |
| 2025-07-31 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2025-07-30 | 재확인 | Oppenheimer | Outperform |
| 2025-06-11 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-05-21 | 다운그레이드 | HSBC Securities | Hold → Reduce |
| 2025-05-19 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-05-14 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-05-14 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2025-04-22 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-04-21 | 다운그레이드 | Argus | Buy → Hold |
| 2025-01-10 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2025-01-06 | 재확인 | Truist | Buy |
| 2024-10-17 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-07-17 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-07-17 | 재확인 | RBC Capital Mkts | Outperform |
| 2024-06-05 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-05-30 | 개시 | Robert W. Baird | Outperform |
| 2024-04-04 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2024-03-06 | 개시 | Barclays | Overweight |
| 2023-12-18 | 다운그레이드 | HSBC Securities | Hold → Reduce |
| 2023-10-16 | 업그레이드 | UBS | Neutral → Buy |
| 2023-09-06 | 개시 | HSBC Securities | Hold |
| 2023-07-19 | 재확인 | UBS | Neutral |
| 2023-07-18 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2023-07-17 | 재확인 | JP Morgan | Overweight |
| 2023-07-17 | 재확인 | RBC Capital Mkts | Outperform |
| 2023-07-17 | 재확인 | TD Cowen | Outperform |
| 2023-05-26 | 개시 | Piper Sandler | Overweight |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-04-05 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2022-11-23 | 재개 | Morgan Stanley | Overweight |
| 2022-11-21 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2022-06-17 | 개시 | Loop Capital | Buy |
| 2022-05-27 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2021-12-14 | 개시 | Goldman | Buy |
| 2021-09-27 | 개시 | SVB Leerink | Outperform |
| 2021-09-10 | 개시 | Cowen | Outperform |
| 2021-07-09 | 개시 | Seaport Global Securities | Buy |
| 2021-06-01 | 재확인 | BofA Securities | Buy |
| 2021-05-19 | 개시 | Wells Fargo | Overweight |
| 2021-04-21 | 업그레이드 | Argus | Hold → Buy |
| 2020-10-19 | 다운그레이드 | Argus | Buy → Hold |
| 2020-07-01 | 재개 | SVB Leerink | Outperform |
| 2020-06-05 | 개시 | Goldman | Buy |
| 2020-03-20 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2019-10-18 | 개시 | Mizuho | Buy |
| 2019-10-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-09-30 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-05-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-04-23 | 개시 | UBS | Neutral |
| 2019-04-17 | 재확인 | BofA/Merrill | Buy |
| 2019-01-14 | 개시 | Stephens | Overweight |
| 2018-09-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-06-11 | 개시 | SunTrust | Buy |
| 2018-03-08 | 개시 | Barclays | Overweight |
| 2018-01-17 | 재확인 | Citigroup | Buy |
| 2018-01-12 | 재확인 | Evercore ISI | Outperform |
| 2018-01-03 | 개시 | Goldman | Buy |
| 2017-07-19 | 재확인 | Mizuho | Buy |
| 2017-06-07 | 개시 | Morgan Stanley | Overweight |
모두보기
유나이티드헬스 그룹 주식(UNH)의 최신 뉴스
3 Companies Raising Guidance This Earnings Season - Zacks Investment Research
3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge - Zacks Investment Research
Can UNH's Focus on Special Needs Plans Strengthen Medicare Growth? - Zacks Investment Research
Centene's Gold Card Push Could Ease CostsBut Will Savings Follow? - Zacks Investment Research
UNH Q3 Earnings Call Highlights 2027 Growth and Margin Recovery - Zacks Investment Research
UnitedHealth Group (UNH) is a Top-Ranked Momentum Stock: Should You Buy? - Zacks Investment Research
UnitedHealth vs. Johnson & Johnson: Which Stock Is the Better Buy After Q3 Earnings? - Zacks Investment Research
Oscar Health Raises 2026 Operating Earnings Outlook as Margins Improve - Zacks Investment Research
Is Oscar Health Stock a Buy as Growth Surges but Valuation Stays Rich? - Zacks Investment Research
Oscar Health Rallies 14.9% in 3 Months: Can the Gains Keep Going? - Zacks Investment Research
Stock Market Midday, Oct. 13: Bank Earnings and Chip Pressure Drive Mixed Trading - The Motley Fool
UNH Tops Q3 Earnings on Lower Medical Costs, Raises '26 Outlook - Zacks Investment Research
UnitedHealth Group (UNH) Q3 Earnings and Revenues Top Estimates - Zacks Investment Research
Middle East Tensions Rattle Markets - Zacks Investment Research
Big Week of Data: Inflation & Q3 Earnings - Zacks Investment Research
Estimates Keep Rising as Q3 Earnings Season Takes Center Stage - Zacks Investment Research
UnitedHealth Group (UNH) Beats Stock Market Upswing: What Investors Need to Know - Zacks Investment Research
UnitedHealth vs. Humana: Which Healthcare Giant Has the Edge? - Zacks Investment Research
UnitedHealth Group (UNH) Registers a Bigger Fall Than the Market: Important Facts to Note - Zacks Investment Research
CVS Health Trades at a Discount to Industry: How to Play the Stock? - Zacks Investment Research
UnitedHealth Gears Up for Q3 Earnings: Should Investors Buy the Stock? - Zacks Investment Research
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know - Zacks Investment Research
Is American Century U.S. Quality Value ETF (VALQ) a Strong ETF Right Now? - Zacks Investment Research
Centene's Operations Improve: Does the 12.34X P/E Make it a Buy? - Zacks Investment Research
UnitedHealth Q3 Coming Up: Two Questions Investors Can't Ignore - Zacks Investment Research
Ensign Builds More Scale as Financial Flexibility Remains Strong - Zacks Investment Research
Centene Narrows Medicare Advantage Footprint as Costs Remain Elevated - Zacks Investment Research
Here's Why UnitedHealth Group (UNH) is a Strong Value Stock - Zacks Investment Research
UnitedHealth Reports on Oct. 13. Here's the 1 Number I'm Watching. - The Motley Fool
UnitedHealth Group Incorporated (UNH) Stock Price, News, Quote & History - Yahoo! Finance Canada
UnitedHealth Group (UNH) Surpasses Market Returns: Some Facts Worth Knowing - Zacks Investment Research
Warren Buffett's Record: $1,000 Became About $61 Million. Can Greg Abel Keep Compounding It? - The Motley Fool
Hatteras Venture Partners Names Sir Andrew Witty as Chairman and Ned Sharpless, M.D., as Managing Director of Hatteras Discovery Innovation, Expanding Proven Investment Strategies - GlobeNewswire Inc.
Reuters Momentum AI Austin Day 1: A New Way to Measure Whether AI Is Actually Paying Off - GlobeNewswire Inc.
Europe Clinical Data Analytics Market Outlook 2026-2033 | AI, Cloud Deployment and Data-Driven Healthcare Adoption Accelerate Across the Region - GlobeNewswire Inc.
UNH vs. MOH: Which Managed Care Stock Looks More Attractive? - Zacks Investment Research
NASP Announces 2026 Industry Award Winners at Record-Breaking inSPire2026 Conference - GlobeNewswire Inc.
UnitedHealth Group stock gains as Q2 2026 beat and raised outlook draw analyst support - ad-hoc-news.de
Dear UnitedHealth Stock Fans, Mark Your Calendars for October 1 - Barchart.com
Why Has UnitedHealth Group (UNH) Become a Talking Point? - Kalkine Media
UnitedHealth Group Incorporated • Robinhood Token (UNH) Preț Azi - bybit.com
UnitedHealth Group (UNH) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
What's Going On With UnitedHealth Stock Friday?UnitedHealth Group (NYSE:UNH) - Benzinga
Can Centene's Medicare Advantage Strategy Unlock Better Margins? - Zacks Investment Research
UnitedHealth sells stake in Florida WellMed clinics - Healthcare Finance News
UnitedHealth Group (NYSE:UNH): Still Cheap After Gains? - Kalkine Media
UnitedHealth Group stock slips as Medicare Advantage margins stay in focus - ad-hoc-news.de
Dividend Roundup: Meta Platforms, Verizon, UnitedHealth Group, Coca-Cola, and more - Seeking Alpha
Cantor Fitzgerald reiterates UnitedHealth stock rating on Stars outlook - Investing.com
UnitedHealth Group stock heads into the open after a 1.2 percent drop - ad-hoc-news.de
유나이티드헬스 그룹 (UNH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
유나이티드헬스 그룹 주식 (UNH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Conway Patrick Hugh | Officer |
Aug 21 '26 |
Proposed Sale |
390.00 |
1,169 |
455,910 |
0 |
| Conway Patrick Hugh | Chief Executive Officer, Optum |
Aug 05 '26 |
Sale |
410.00 |
500 |
205,000 |
16,497 |
| Conway Patrick Hugh | Officer |
Aug 05 '26 |
Proposed Sale |
410.00 |
500 |
205,000 |
0 |
| Conway Patrick Hugh | Chief Executive Officer, Optum |
Apr 23 '26 |
Sale |
355.00 |
800 |
284,000 |
17,805 |
| Conway Patrick Hugh | Officer |
Apr 23 '26 |
Proposed Sale |
355.00 |
800 |
284,000 |
0 |
0.24%
1.17%
자본화:
|
볼륨(24시간):